🇺🇸 FDA

Company profile · Sponsor

Shanghai

Shanghai Zhongshan Hospital

C718A4D · NMPA pharma CN
Pipeline
3
Drugs
0
Patents
0

Quick answer

Shanghai (C718A4D) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C718A4D
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (3)

Search pipeline →

  1. Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles (hUCMSC-EVs)

    Shanghai

    Interstitial Lung Disease (ILD)

    phase 1 mab active

    1 trial

  2. Tocilizumab

    Shanghai

    Takayasu Arteritis

    approved mab active

    1 trial

  3. Norepinephrine

    Shanghai

    Gastrointestinal Disease

    small molecule active

    1 trial

Frequently asked questions

What is Shanghai?

Shanghai (C718A4D) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Shanghai sponsor?

We track 3 ClinicalTrials.gov-linked programs for Shanghai, including Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles (hUCMSC-EVs) and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Shanghai company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.